More countries around the world are consolidating procurement to drive down the price of medical technologies. While they have been successful, the impact on the total cost of healthcare has been limited. In some cases, the narrow focus on price, rather than value, has had a detrimental impact on the patient experience, the healthcare provider experience, and the system’s ability to access innovative technologies.
In several countries where procurement consolidation has been happening for a while, health systems and procurement agencies are shifting their attention to how they can leverage procurement to improve key performance measures.
This session will provide several examples of how procurement agencies around the world have leveraged value-based procurement to deliver greater value to the healthcare systems they support.